GLP-1 drugs show promise in mitigating addiction risk, but underlying causes remain unaddressed
Original framing: “GLP-1 drugs protect against new or worsening addictions, large study shows - Reuters” — Reuters (via Google News)
The history of addiction treatment is marked by a legacy of racism, classism, and ableism, which has led to the marginalization of certain populations and the prioritization of profit-driven interests over community-based interventions. To truly address addiction, we must acknowledge and confront this history and work towards a more equitable and just approach to addiction treatment.
The GLP-1 drug study highlights the need for a more nuanced understanding of addiction, one that acknowledges the complex interplay between biological, environmental, and socioeconomic factors.
To truly address addiction, we must prioritize community-based interventions, cultural sensitivity, and a commitment to addressing the root causes of addiction. This requires a commitment to policy changes that prioritize community-based interventions, cultural sensitivity, and a nuanced understanding of the complex interplay between addiction, culture, and community. By centering Indigenous knowledge and perspectives, we can develop more effective and culturally sensitive addiction treatment strategies that prioritize healing and recovery. Ultimately, a comprehensive approach to addiction treatment must prioritize the experiences and perspectives of individuals in recovery, tailoring interventions to the unique needs and experiences of each individual and community.